Lucid Diagnostics Inc reports results for the quarter ended in December - Earnings Summary
25/03/2024 22:19
* Lucid Diagnostics Inc LUCD.OQ reported a quarterly
adjusted
loss of 25 cents per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -23 cents. The mean expectation of six analysts for the
quarter was for a loss of 26 cents per share. Wall Street
expected results to range from -30 cents to -19 cents per share.
* Revenue rose 828.6% to $1.04 million from a year ago;
analysts
expected $1.05 million.
* Lucid Diagnostics Inc's reported EPS for the quarter was a
loss
of 25 cents.
* The company reported a quarterly loss of $10.83 million.
* Lucid Diagnostics Inc shares had fallen by 22.7% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Lucid Diagnostics
Inc is $3.40
This summary was machine generated from LSEG data March 25 at
10:19 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.26 -0.25 Beat
Sep. 30 2023 -0.27 -0.34 Missed
Jun. 30 2023 -0.32 -0.23 Beat
Mar. 31 2023 -0.35 -0.40 Missed